Scientists track pregnancy outcomes years after RSV vaccination
NCT ID NCT05705440
Summary
This study followed people who had received an RSV vaccine or a placebo in earlier trials to see if the vaccine affected their health or their baby's health in pregnancies that happened later. It did not give any new treatments; it only collected safety information from over 3,800 participants for up to two years after their original vaccination. The goal was to understand the long-term safety of the RSV vaccine for future pregnancies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Mobile, Alabama, 36608, United States
-
GSK Investigational Site
Phoenix, Arizona, 85015, United States
-
GSK Investigational Site
Tucson, Arizona, 85712, United States
-
GSK Investigational Site
Burbank, California, 91506, United States
-
GSK Investigational Site
Los Angeles, California, 90057, United States
-
GSK Investigational Site
Nampa, Idaho, 83686, United States
-
GSK Investigational Site
Nampa, Idaho, 83702, United States
-
GSK Investigational Site
Covington, Louisiana, 70433, United States
-
GSK Investigational Site
Slidell, Louisiana, 70458, United States
-
GSK Investigational Site
Detroit, Michigan, 48201, United States
-
GSK Investigational Site
Saginaw, Michigan, 48604, United States
-
GSK Investigational Site
Biloxi, Mississippi, 39531, United States
-
GSK Investigational Site
Albuquerque, New Mexico, 87107, United States
-
GSK Investigational Site
Englewood, Ohio, 45322, United States
-
GSK Investigational Site
Greenville, South Carolina, 29607, United States
-
GSK Investigational Site
Hendersonville, Tennessee, 29708, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
Fort Worth, Texas, 76104, United States
-
GSK Investigational Site
Houston, Texas, 77008, United States
-
GSK Investigational Site
Keller, Texas, 76012, United States
-
GSK Investigational Site
Keller, Texas, 76028, United States
-
GSK Investigational Site
Keller, Texas, 76051, United States
-
GSK Investigational Site
Lampasas, Texas, 76550, United States
-
GSK Investigational Site
Plano, Texas, 75093, United States
-
GSK Investigational Site
Weatherford, Texas, 76086, United States
-
GSK Investigational Site
Norfolk, Virginia, 68701, United States
-
GSK Investigational Site
Seattle, Washington, 98104, United States
-
GSK Investigational Site
Buenos Aires, 1425, Argentina
-
GSK Investigational Site
Córdoba, 5800, Argentina
-
GSK Investigational Site
South Brisbane, Queensland, 4101, Australia
-
GSK Investigational Site
Southport, Queensland, 4215, Australia
-
GSK Investigational Site
Clayton, Victoria, 3168, Australia
-
GSK Investigational Site
Matlab, Bangladesh
-
GSK Investigational Site
Sylhet, 3100, Bangladesh
-
GSK Investigational Site
Ghent, 9000, Belgium
-
GSK Investigational Site
Leuven, 3000, Belgium
-
GSK Investigational Site
Sint-Niklaas, 9100, Belgium
-
GSK Investigational Site
Nova Iguaçu, 26030-380, Brazil
-
GSK Investigational Site
Porto Alegre, 90035001, Brazil
-
GSK Investigational Site
RibeirAo PretoSP, 14051-140, Brazil
-
GSK Investigational Site
Santa Maria, 97105-900, Brazil
-
GSK Investigational Site
São José do Rio Preto, 15090-000, Brazil
-
GSK Investigational Site
Surrey, British Columbia, V3S 2N6, Canada
-
GSK Investigational Site
Vancouver, British Columbia, V6Z 2T1, Canada
-
GSK Investigational Site
Halifax, Nova Scotia, B3K 6R8, Canada
-
GSK Investigational Site
Truro, Nova Scotia, B2N 1L2, Canada
-
GSK Investigational Site
Kingston, Ontario, K7L 2V7, Canada
-
GSK Investigational Site
London-Ontario, Ontario, N5W 6A2, Canada
-
GSK Investigational Site
Sarnia, Ontario, N7T 4X3, Canada
-
GSK Investigational Site
Toronto, Ontario, M9W 4L6, Canada
-
GSK Investigational Site
Joliette, Quebec, J6E 6A9, Canada
-
GSK Investigational Site
Montreal, Quebec, H3T 1C5, Canada
-
GSK Investigational Site
Montreal, Quebec, H9R 4S3, Canada
-
GSK Investigational Site
Montreal, Quebec, J7J 2K8, Canada
-
GSK Investigational Site
Québec, Quebec, G1V 4G2, Canada
-
GSK Investigational Site
Québec, Quebec, G1W 4R4, Canada
-
GSK Investigational Site
Sherbrooke, Quebec, J1L 0H8, Canada
-
GSK Investigational Site
Barranquilla, 760002, Colombia
-
GSK Investigational Site
Cali Colombia, 760042, Colombia
-
GSK Investigational Site
Chía, 250001, Colombia
-
GSK Investigational Site
Medellín, 050034, Colombia
-
GSK Investigational Site
Santo Domingo Este, Dominican Republic
-
GSK Investigational Site
Espoo, 02230, Finland
-
GSK Investigational Site
Helsinki, 00100, Finland
-
GSK Investigational Site
Helsinki, 00290, Finland
-
GSK Investigational Site
Helsinki, 00930, Finland
-
GSK Investigational Site
Jarvenpaa, 04400, Finland
-
GSK Investigational Site
Kokkola, 67100, Finland
-
GSK Investigational Site
Oulu, 90220, Finland
-
GSK Investigational Site
Pori, 28100, Finland
-
GSK Investigational Site
Seinäjoki, 60100, Finland
-
GSK Investigational Site
Tampere, 33100, Finland
-
GSK Investigational Site
Turku, 20520, Finland
-
GSK Investigational Site
Bordeaux, 33000, France
-
GSK Investigational Site
Bron, 69500, France
-
GSK Investigational Site
Paris, 75679, France
-
GSK Investigational Site
Goch, 47574, Germany
-
GSK Investigational Site
Hamburg, 22143, Germany
-
GSK Investigational Site
Hanover, 30159, Germany
-
GSK Investigational Site
Mainz, 55116, Germany
-
GSK Investigational Site
Würzburg, 97070, Germany
-
GSK Investigational Site
Comayagua, Honduras
-
GSK Investigational Site
San Pedro Sula, 21101, Honduras
-
GSK Investigational Site
Kolkata, 700017, India
-
GSK Investigational Site
Mangalore, 575001, India
-
GSK Investigational Site
Mysore, 570015, India
-
GSK Investigational Site
Nagpur, 441108, India
-
GSK Investigational Site
Pune, 411043, India
-
GSK Investigational Site
Vadu Budruk Pune, 412216, India
-
GSK Investigational Site
Bari, 70124, Italy
-
GSK Investigational Site
Messina, 98124, Italy
-
GSK Investigational Site
Milan, 20154, Italy
-
GSK Investigational Site
Prato, 59100, Italy
-
GSK Investigational Site
Grafton Auckland, 1010, New Zealand
-
GSK Investigational Site
Papatoetoe Auckland, 1701, New Zealand
-
GSK Investigational Site
Wellington, 6002, New Zealand
-
GSK Investigational Site
Panama City, 07079, Panama
-
GSK Investigational Site
Panama City, 0801, Panama
-
GSK Investigational Site
Panama City, 1001, Panama
-
GSK Investigational Site
Panama City, 7099, Panama
-
GSK Investigational Site
Manila, 1000, Philippines
-
GSK Investigational Site
Manila, 1008, Philippines
-
GSK Investigational Site
Johannesburg, 2112, South Africa
-
GSK Investigational Site
Pretoria, 0184, South Africa
-
GSK Investigational Site
Soshanguve, 0152, South Africa
-
GSK Investigational Site
Soweto Gauteng, 2013, South Africa
-
GSK Investigational Site
Ansan, 425-707, South Korea
-
GSK Investigational Site
Seoul, 08308, South Korea
-
GSK Investigational Site
Seoul, South Korea
-
GSK Investigational Site
Aravaca, 28023, Spain
-
GSK Investigational Site
Barcelona, 08035, Spain
-
GSK Investigational Site
Bilbao, 48013, Spain
-
GSK Investigational Site
Boadilla Del Monte Madrid, 28660, Spain
-
GSK Investigational Site
Burgos, 09006, Spain
-
GSK Investigational Site
Getafe, 28905, Spain
-
GSK Investigational Site
Madrid, 28006, Spain
-
GSK Investigational Site
Madrid, 28007, Spain
-
GSK Investigational Site
Madrid, 28034, Spain
-
GSK Investigational Site
Madrid, 28041, Spain
-
GSK Investigational Site
Madrid, 28046, Spain
-
GSK Investigational Site
Madrid, 28222, Spain
-
GSK Investigational Site
Madrid, 28400, Spain
-
GSK Investigational Site
Marbella, 29603, Spain
-
GSK Investigational Site
Málaga, 29004, Spain
-
GSK Investigational Site
Santiago de Compostela, 15706, Spain
-
GSK Investigational Site
Seville, 41013, Spain
-
GSK Investigational Site
Seville, 41014, Spain
-
GSK Investigational Site
TorrejOn Ardoz Madrid, 28850, Spain
-
GSK Investigational Site
Valencia, 46017, Spain
-
GSK Investigational Site
Valencia, 46020, Spain
-
GSK Investigational Site
Valencia, 46702, Spain
-
GSK Investigational Site
Valladolid, 47012, Spain
-
GSK Investigational Site
Taichung, 40447, Taiwan
-
GSK Investigational Site
Taipei, 0105, Taiwan
-
GSK Investigational Site
Taipei, 10041, Taiwan
-
GSK Investigational Site
Taoyuan District, 333, Taiwan
-
GSK Investigational Site
Bangkok, 10330, Thailand
-
GSK Investigational Site
Chiang Mai, 50200, Thailand
Conditions
Explore the condition pages connected to this study.